SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-006465
Filing Date
2018-05-09
Accepted
2018-05-09 16:01:10
Documents
49
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form-10q.htm 10-Q 281949
2 ex10-1.htm EX-10.1 3252
3 ex10-2.htm EX-10.2 3063
4 ex10-3.htm EX-10.3 2925
5 ex10-4.htm EX-10.4 3063
6 ex31-1.htm EX-31.1 19057
7 ex31-2.htm EX-31.2 19074
8 ex32.htm EX-32 8943
9 ex10-1_001.jpg GRAPHIC 197185
10 ex10-1_002.jpg GRAPHIC 117465
11 ex10-1_003.jpg GRAPHIC 65023
12 ex10-2_001.jpg GRAPHIC 201257
13 ex10-2_002.jpg GRAPHIC 45010
14 ex10-2_003.jpg GRAPHIC 65175
15 ex10-3_001.jpg GRAPHIC 194654
16 ex10-3_002.jpg GRAPHIC 22883
17 ex10-3_003.jpg GRAPHIC 64598
18 ex10-4_001.jpg GRAPHIC 194258
19 ex10-4_002.jpg GRAPHIC 21477
20 ex10-4_003.jpg GRAPHIC 80920
  Complete submission text file 0001493152-18-006465.txt   3062541

Data Files

Seq Description Document Type Size
21 XBRL INSTANCE FILE pvct-20180331.xml EX-101.INS 96183
22 XBRL SCHEMA FILE pvct-20180331.xsd EX-101.SCH 17256
23 XBRL CALCULATION FILE pvct-20180331_cal.xml EX-101.CAL 25318
24 XBRL DEFINITION FILE pvct-20180331_def.xml EX-101.DEF 72294
25 XBRL LABEL FILE pvct-20180331_lab.xml EX-101.LAB 135178
26 XBRL PRESENTATION FILE pvct-20180331_pre.xml EX-101.PRE 105477
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36457 | Film No.: 18818167
SIC: 2834 Pharmaceutical Preparations